121 related articles for article (PubMed ID: 13355059)
1. [The pathogenesis of alloxan diabetes. IV. Hyperglycemia after B.A.L. and glucose].
DE MOOR P; VAN HAELST C
Ann Endocrinol (Paris); 1956 Jul; 17(2):299-301. PubMed ID: 13355059
[No Abstract] [Full Text] [Related]
2. The effect of insulin administration on arteriovenous glucose differences in the alloxan-diabetic dog.
GRAY DE; DELUCA HA
Can J Biochem Physiol; 1956 Jul; 34(4):763-7. PubMed ID: 13343037
[No Abstract] [Full Text] [Related]
3. The glycaemic response of rabbits to 1-adrenaline and 1-noradrenaline and the effect thereon of dimercaprol.
GRAHAM JD; JAMES DM
J Physiol; 1952 Dec; 118(4):479-85. PubMed ID: 13023645
[No Abstract] [Full Text] [Related]
4. The effects of graded doses of alloxan on the blood sugar of the mouse.
MOUNT LE
J Physiol; 1951 Sep; 115(1):52-3 P. PubMed ID: 14898505
[No Abstract] [Full Text] [Related]
5. [Experimental study of the effect of BZ 55 on normal or alloxan-treated rats. II. Effect on blood sugar].
BELLENS R; CHRISTOPHE J; GEPTS W
Ann Endocrinol (Paris); 1956 Jul; 17(2):291-8. PubMed ID: 13355058
[No Abstract] [Full Text] [Related]
6. Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
Ader M; Richey JM; Bergman RN
Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941
[TBL] [Abstract][Full Text] [Related]
7. The effect of methylene blue in preventing alloxan diabetes and in lowering the blood sugar of alloxan-diabetic rats.
HIGHET DM; WEST ES
J Biol Chem; 1949 Mar; 178(1):521. PubMed ID: 18112136
[No Abstract] [Full Text] [Related]
8. [Inhibition of diabetogenic effect of alloxan by intraperitoneal administration of glucose in mice].
Ratsimamanga AR; Chirvan-Nia P; Bibal-Prot P
C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(6):599-602. PubMed ID: 4989914
[No Abstract] [Full Text] [Related]
9. Hypoglycemic effect of ethanolic extract of Musa sapientum on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential.
Dhanabal SP; Sureshkumar M; Ramanathan M; Suresh B
J Herb Pharmacother; 2005; 5(2):7-19. PubMed ID: 16260406
[TBL] [Abstract][Full Text] [Related]
10. Early hyperglycemia following alloxan administration in vivo is not associated with altered hepatic mitochondrial function: acceptable model for type 1 diabetes?
Rendon DA; Alvarez-Bustamante JA
Can J Physiol Pharmacol; 2011 Jul; 89(7):477-84. PubMed ID: 21780865
[TBL] [Abstract][Full Text] [Related]
11. Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice.
Ma L; Zhang S; Du M
Nutr Res; 2015 May; 35(5):431-9. PubMed ID: 25940982
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of vitamin B
Abdullah KM; Alam MM; Iqbal Z; Naseem I
Biomed Pharmacother; 2018 Sep; 105():1223-1231. PubMed ID: 30021358
[TBL] [Abstract][Full Text] [Related]
13. [Benzylimidazoline and its effect on basal glycemia and cholesterinemia in alloxanized dogs].
GANDOLFO G; BELLOMO A
Sicil Sanit; 1953 Feb; 6(2):112-20. PubMed ID: 13076569
[No Abstract] [Full Text] [Related]
14. Studies on the mechanism of primary alloxan hyperglycemia and hypoglycemia in rabbits.
MAZUMDER R; BANERJEE S
Indian J Med Res; 1955 Oct; 43(4):667-77. PubMed ID: 13278037
[No Abstract] [Full Text] [Related]
15. Hypoglycemic and antiperglycemic effects of Semecarpus anacardium linn in normal and alloxan-induced diabetic rats.
Kothai R; Arul B; Kumar KS; Christina AJ
J Herb Pharmacother; 2005; 5(2):49-56. PubMed ID: 16260409
[TBL] [Abstract][Full Text] [Related]
16. Studies on the protective effect of diphenylhydantoin against alloxan diabetes in mice.
Esposito-Avella M; Mennear JH
Proc Soc Exp Biol Med; 1973 Jan; 142(1):82-5. PubMed ID: 4683268
[No Abstract] [Full Text] [Related]
17. Antihyperglycaemic effect and acute toxicity of Securigera Securidaca L. seed extracts in mice.
Hosseinzadeh H; Ramezani M; Danaei AR
Phytother Res; 2002 Dec; 16(8):745-7. PubMed ID: 12458478
[TBL] [Abstract][Full Text] [Related]
18. Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs.
Rizza RA; Westland RE; Hall LD; Patton GS; Haymond MW; Clemens AH; Gerich JE; Service FJ
Mayo Clin Proc; 1981 Jul; 56(7):434-8. PubMed ID: 7019592
[TBL] [Abstract][Full Text] [Related]
19. [Action of insulin and glucagon liver perfusion of frogs, rabbits and dogs, both normal and alloxanic diabetic].
JAUREGUI RH
Medicina (Mex); 1956 Nov; 36(759):503-16. PubMed ID: 13377910
[No Abstract] [Full Text] [Related]
20. Oral Efficacy of BAL in Protecting Rats Against Alloxan Diabetes.
Chesler A; Tislow R
Science; 1947 Oct; 106(2754):345. PubMed ID: 17777426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
